Tuesday, November 29, 2011

Roche, PTC Sign $490M Deal for Genetic Disease Program - Nov. 29, 2011

BioSpace GenePool
   Tuesday, November 29, 2011 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Assay Depot has created the world's largest network of public and private cloud-based Research Exchanges:

Life science researchers from 53 countries use our public Research Exchange to find, create and purchase research services and products and to communicate with 5000+ research vendors.

Pharmaceutical companies, universities and non-profit organizations use a private Research Exchange to manage and strengthen internal and external research partnerships.

Research vendors use public and private Research Exchanges to offer their services and products to the global research community.

Researchers - Use our free public marketplace at assaydepot.com.
Vendors - Get a free vendor account at http://backoffice.assaydepot.com/.
Top Stories 
•  Roche (RHHBY) and PTC Therapeutics, Inc. Sign $490 Million Deal for Genetic Disease Program More...
•  Immuron Signs Distribution Deal Worth Up to $113 Million More...
•  Infinity Pharmaceuticals Inc. (INFI) Gets $50 Million More in Mundipharma International Limited Deal More...
•  Onyx Pharmaceuticals, Inc. (ONXX) Announces FDA Acceptance of New Drug Application for Carfilzomib for the Treatment of Relapsed and Refractory Multiple Myeloma More...
•  Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE) Report FDA's Acceptance of Eliquis NDA for Priority Review More...
•  CELLMED Research GmbH Assigns New CEO to Push Clinical Program More...
•  Warnex Inc. (CC:WNX) Announces Resignation of Its President & CEO More...
•  Horizon Pharma, Inc. Announces U.S. FDA Acceptance of LODOTRA(R) New Drug Application for Review for the Treatment of Rheumatoid Arthritis More...

More Top News
Don't Miss This

Download PPD's new whitepaper, Managing Clinical Trials and Central Laboratory Services in China.

China is expected to become the second largest pharmaceutical market by 2015. Yet only 152 international, multicenter clinical trials were initiated in China in 2010 despite creation of a centralized State Food and Drug Administration (SFDA), improvements in pharmaceutical industry regulations and growing clinical trial infrastructure.

In our new white paper, we detail the recent advancements and remaining challenges in China's regulatory environment and expanding clinical trial infrastructure. We also provide insight into the benefits of leveraging global contract research organizations and the efficiencies gained by integrating central laboratory services along with clinical trial management.

Click here to view the whitepaper.
Featured Stories
•  How Does Laptop Wi-Fi Affect Male Fertility? Journal of Fertility and Sterility Reveals More...
•  Heading Soccer Balls Can Lead to Brain Damage, Albert Einstein College of Medicine Study More...
•  Scientists Discover Gene That Allows People to Get by on Four Hours Sleep, Ludwig-Maximilians-University Study More...
•  Could Slow Eating Be Key to Staying Slim? University of Rhode Island Study More...
•  Growth Hormone Increases Bone Formation in Obese Women, Harvard Medical School Study More...
•  Research Group Develops More Efficient Artificial Enzyme More...
•  Aging Stem Cells May Explain Higher Prevalence of Leukemia, Infections Among Elderly, Stanford University Study More...
•  Brain Pathways Seem Disrupted in Kids With ADHD, Albert Einstein College of Medicine Study More...
Tower: Facebook
 
More Featured News
Event of the day

Better Antibodies Through Better Antigen Design

Join SDIX at the Boston Cambridge Marriott on December 8th, 2011 for a symposium focused on next generation antibody development. At SDIX, a focus on the philosophy of better antigen design has resulted in dramatic improvements to the antibody production process. In a series of talks, our scientists and collaborators will discuss this antigen design philosophy and provide case studies to demonstrate the effectiveness of this methodology. In particular, these talks will focus on the use of SDIX's proprietary Genomic Antibody Technology™ and its ability to deliver antibodies that match end users' requirements.

Please click here for more information.
Latest Market Insight

Next-Generation Protein and Peptide Therapeutics

• Understand the limitations of monoclonal antibodies, how these relate to molecular structure, and which protein alternatives may offer solutions.
• Discover the most innovative delivery technologies that may broaden the applicability of protein therapeutics.
• Gain insight into the crucial issue of immunogenicity; understand the regulatory expectations for testing, and the potential options for minimizing.
• Compare the pros and cons of the next-generation protein therapeutics, and assess which are making progress through the clinic.

Click Here for More Information.


Featured Free Resource

Quantifying the Value of Pipeline Pilot, the Accelrys Scientific Enterprise Platform

This white paper outlines the methodology, sources of value, and quantifiable results from bringing products to market faster, avoiding unproductive experiments, saving developer time, and more.

Request Now!
Top Jobs
Pharm Country (Farmingdale, New York)

Astellas Pharma US
Development Scientist
Assists with the analysis and characterization of discovery nominated compounds, through the early stages of development, to gain regulatory approval for clinical trial initiations.

BioMidwest (Urbana, Illinois)

Carle Foundation Hospital
Vice President of Research & Graduate Medical Education
Responsible for administrative and financial oversight for Carle's Research Institute and its Graduate Medical Education program. This position will function in alliance with the physician leaders over research and graduate medical education.

Biotech Beach (San Diego, California)

Pfizer Inc.
Senior Scientist (CovX)
Primary responsibilities will include guiding and accelerating the optimization of therapeutic peptides as well as designing the enhanced carrier proteins used as conjugation or fusion platforms.

Genetown (Cambridge, Massachusetts)

Vertex
Associate Director, GIS Client Account Management
Responsible for understanding the business, specifically the Global Patient Safety (GPS) function, assist in the prioritization of projects, ensure that projects align with the technology that provides the best possible value to GPS in the context of the overall GIS strategy and influence IT strategy in support of the overall business strategy.

Biotech Bay (Foster City, California)

Life Technologies
Senior Product Applications Specialist
Responsible for providing a broad range of support for product development projects, troubleshooting and pre-sales and post-sales activities for products involved in QA/QC testing in pharmaceutical manufacturing.

Get Noticed! Add your resume to the BioSpace Career Center!
See more than 5,000 job postings in the BioSpace Career Center!
BioSpace Career Fairs

BioSpace Life Science Career Fairs are the biotech industry's premier career events. Featuring well-respected employers from around the nation, our job fairs attract top candidates in the biotech, pharmaceutical, life science and medical device industries.

With such a great number of recruiters and hiring managers from top biotech companies attending our career fairs, there are an abundance of opportunities available for job seekers. Many different disciplines within the industry are represented bringing a diversity of candidates to our job fairs.

Companies seeking pharmaceutical sales representatives and marketing jobs regularly attend our job fairs. Engineering and technical jobs can be found, as well as regulatory jobs and positions in QA/QC. Individuals desiring a science job or a research job will find many opportunities at our job fairs. In addition, hiring managers seeking candidates for clinical research jobs also attend our events.

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
Company of the day

Human Genome Sciences, Inc.
14200 Shady Grove Road
Rockville, Maryland 20850 U.S.A.
Phone: 301-309-8504 Fax: 301-309-8512

Human Genome Sciences (HGS) is located in the Washington, DC metro area, and was founded in 1992 with the goal of creating a global biopharmaceutical company to discover, develop, manufacture, and market gene-based drugs to address unmet medical needs.

More Company Profiles
Free Resources
FREE Subscription to Pharmaceutical Executive Global Digest

Tackling strategic business and marketing issues, Pharmaceutical Executive Global Digest provides complete high-quality analysis, opinion and industry news on critical trends and developments; sales and marketing strategies; corporate policy, management and branding; research and development; legislation; finance; new technologies and much more.
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

BioSpace Inc.
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
BioSpace Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the BioSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

BioSpace.com - Life. Science. Community.
Legal Notice

• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2011 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.



No comments: